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Regulation  of the  immune  response  to antigen  involves the  interactions  of many 
cell types. There is substantial  evidence attesting to the decisive role of suppressor T 
cells in the inhibition of both humoral (1)  and cell-mediated  (2) immune reactivity to 
a  variety of antigens. In addition,  regulatory molecules derived from such suppressor 
T  cells have been identified  in a  number of experimental  systems (reviewed in 3, 4). 
Suppressor  T  cells  (Ts) 1 operative  in  regulating  responses  to many antigens  have 
been  shown  to  express  certain  Lyt  differentiation  markers,  as  well  as  structures 
encoded by the I subregion of the H-2 major histocompatibility complex (MHC)  (5). 
Furthermore, antigen-specific Ts-derived suppressor factors (TsF) have been found in 
many different systems to bear determinants encoded by the I-J subregions of the H- 
2 MHC  (3,  4).  Despite the above mentioned information,  the mechanisms by which 
Ts and TsF exert  their  inhibitory effect  is complex and  not completely understood. 
Moreover,  the  precise  number of phenotypically  distinct  Ts and  TsF  has  not  been 
determined. As a result, it has not been possible to formulate a single, all encompassing 
scheme  which  can  explain  related  data  from  many  different  laboratories,  each 
employing distinct  experimental  systems. 
In an attempt  to elucidate  the role of antigen-specific Ts and their factor(s)  in the 
regulation  of cell-mediated  immune  response,  over the  past  3  y, our laboratory  has 
been  studying  delayed-type  hypersensitivity  (DTH)  to  the  p-azobenzenearsonate 
(ABA) hapten  (6-8). Conjugates of this hapten evoke an anti-ABA antibody response 
in certain strains of mice, in which the antibody molecules bear cross-reactive idiotypic 
(CRI) structures and can be detected by anti-idiotypic antiserum. 
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Previous  studies  have  revealed  that  syngeneic  cells  conjugated  with  ABA  and 
injected subcutaneously stimulate hapten-specific DTH. In contrast, a state of hapten- 
specific tolerance and the induction  of ABA-specific Ts results when hapten-coupled 
syngeneic cells are injected i.v. (6). These Ts can be enriched on p-azobenzenearsonate- 
coupled syngeneic spleen cells (ABA-BSA)-coated dishes. Moreover, in vitro treatment 
of such  ABA-specific Ts  with  well-defined  anti-cross-reactive  idiotypic  (anti-CRI) 
antibodies and complement before transfer results in a complete loss of their suppres- 
sive activity (Dietz,  M.  H. et al.  Manuscript  in preparation.).  Thus, Ts induced  by 
antigen-coupled spleen cells  (ABA-SC)  bear idiotypic determinants on their surface 
and these determinants presumably mediate hapten binding.  Furthermore, TsF can 
be obtained from these Ts either by in vitro culture or by physical disruption  (7).  In 
addition  to I-J-controlled specificities, ABA-specific TsF also bear idiotypic determi- 
nants, the expression of which is linked to the heavy-chain allotype linkage group of 
genes  (8).  Therefore,  it has been postulated  that  TsF utilize  the variable portion of 
the Ig heavy chain (VH) gene products in the construction of the antigen-binding site. 
Another  intriguing  aspect  of the  immune  regulatory  suppressor  pathway  is  the 
observation that many TsF, when administered to naive recipients or co-cultured with 
normal spleen cells,  appear to induce  second-order Ts.  This phenomenon  has been 
studied extensively with TsF specific for the synthetic copolymers u-glutamic acid 6°- 
L-alaninea°-L-tyrosine  1°  (GAT),  and  L-glutamic acid~°-L-tyrosine  5°  (GT)  (9-11),  and 
independently with carrier specific TsF by Tada and his colleagues (3,  12). 
Based on these observations, it was postulated that administration of antigen under 
appropriate  conditions  will  activate  first-order suppressor T  cells  (Tsl),  capable of 
producing  antigen-specific TsF.  This TsF  in  turn  stimulates  another population  of 
regulatory cells to develop into a  mature second-order suppressor cell, referred to as 
Tsz  (11,  13). However,  the  communications  within  this  regulatory  T  cell  circuit 
remain imprecisely defined (11-13). 
The  experiments  presented  in  this  paper  document  that  in  the  ABA-specific 
suppressor system, I-J  + TsF obtained from antigen-induced  ABA-specific Tsl, when 
injected  into  normal  animals,  also  activate second-order suppressor T  cells.  In this 
system,  a  comparative  analysis  could  be  made  of the  respective specificity of the 
factor-producing Tsl  and  the  factor-induced  Ts2.  In contrast  with  antigen-induced 
Tsl,  which  bears  idiotype,  these  Tsz  are  shown  to  express  anti-idiotypic  receptors. 
Thus, the interaction between TsF and its target, Ts2, are mediated by idiotype and 
anti-idiotype recognition.  Both ABA-specific Tsa and anti-CRI-bearing Tsz suppress 
the generation of ABA DTH equally. The significance of these findings in relationship 
to the network theory of the immune response and the role of Tsz in suppression will 
be discussed. 
Materials and Methods 
Mice.  A/J  (H-2  a, Igh-1 e)  female mice were obtained from The Jackson Laboratory, Bar 
Harbor,  Maine.  All  animals  in  these  experiments were  10-12  wk  old  at  the  time  of the 
experiment. All experimental groups consisted  of at least four animals per group. 
Preparation of Antigen and Antigen-coupled Spleen Cells.  These have been  described  in  detail 
elsewhere  (6). Briefly, a 40 mM solution of ABA diazonium salt was prepared from arsanilic 
acid  (Eastman Kodak Co.,  Rochester,  N.Y.).  The ABA solution  was activated as previously 
described  and conjugated to single cell suspensions  of erythrocyte-free spleen  cells at a  final 
concentration of 10 mM ABA. After washing twice in Hanks' balanced salt solution  (HBSS), 
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Induction and Elicitation of DTH to ABA.  Briefly, to induce DTH  to ABA, 3  ×  10 7 ABA-SC 
were injected subcutaneously into two separate sites on the dorsal flanks of mice. Challenge was 
administered  5 d  later by injecting 30/~1 of a  solution of 10 mM ABA diazonium salt  into the 
left footpad.  24 h  later, DTH reactivity was assessed by measuring the footpad swelling using 
a Fowler micrometer (Schlesinger's Tools, Brooklyn, N.Y.). The magnitude of the DTH reaction 
was expressed as the increment of thickness of the challenged left footpad as compared with the 
untreated  right footpad in  10  -3 in +_ SEM. 
Induction and Assay of Ts and TsF.  Normal A/J mice were injected intravenously with 5 X  10 7 
ABA-SC. 7 d later, these mice served as donors of Ts. Spleens from such animals were removed, 
and a single cell suspension was prepared  in HBSS. The cells were washed twice in HBSS and 
counted. To assay for the ability of such cells to inhibit ABA-specific DTH, 5 X  10 v viable cells 
were  injected  i.v.  into  normal  recipients,  which  were  then  primed  s.c.  with  ABA-SC  and 
challenged 5 d  later. Production of TsF was done precisely as described earlier (7).  Briefly, 1  5 
x  108 washed spleen cells in  1 ml of HBSS were subjected to alternate snap freezing at -78°C 
and  thawing  at  37°C.  This  was  repeated  four times  and  was  followed by  centrifugation  at 
10,000 g for 90 min and/or at  100,000 g for 45 rain. The supernatants  were adjusted to 5 x  108 
cell equivalents/ml and frozen until use at  -40°C. To test  the ability of TsF to inhibit ABA- 
specific DTH, TsF was injected i.v. into normal  mice beginning at  the time of immunization 
with  3  X  107  ABA-SC. 2  X  107  cell equivalents of factor  were administered  each  day  for  5 
successive d, at which time the animals were challenged and their footpad responses measured 
(7). To induce suppressor cells, TsF (2 X  10  v cell equivalents/day) was injected i.v. into normal 
A/J mice for 5 successive d  (13).  On day 7, spleen cells were assayed for suppressive activity by 
adoptive transfer to normal recipients immunized and challenged as described above. 
Antiserum  Treatment.  Anti-Thy  1.2  hybridoma  antiserum  was  kindly  provided  by  Dr.  P. 
Lake, University College, London,  England.  Antisera to the CRI of A/J anti-ABA antibodies 
were prepared and quantitated as described (14).  1 X  10  s spleen cells were incubated with 1 ml 
of 1:20 dilution of anti-Thy  1.2 hybridoma antibody or 25/~g idiotype-binding capacity (IBC) 
of the anti-CRI  antibodies  in  1 ml  of 45  minutes  at  0°C,  washed  once  in  HBSS,  and  then 
incubated  again  with  1 ml  of a  1:10  dilution  of Low  Tox  rabbit  complement  (Cedarlane 
Laboratories Ltd., London, Ontario, Canada)  for 30 min at 37°C. The cells were then washed 
twice in HBSS, recounted, and resuspended  for cell transfer. 
Affinity Chromatography of  ABA Suppressor  Factor.  Solid-phase immunoadsorbent columns were 
prepared  and  characterized  as  described  earlier  (7,  8).  Anti  I-J  k antiserum  was  prepared  by 
immunizing  (DBA/2  ×  B10.A[3R])F1  mice  with  BI0.A(5R)  lymphocytes  and  was  kindly 
provided by Dr. M. E. Dorf, the Department  of Pathology, Harvard  Medical School, Boston, 
Mass. Soluble ABA suppressor factor(s) were fractionated on immunoadsorbents in the following 
manner.  5-ml  plastic columns  containing  Sepharose 4B  (Pharmacia  Fine Chemicals,  Div. of 
Pharmacia, Inc., Piscataway, N.J.) conjugated with the relevant immunoglobulin were prepared 
and  extensively washed  with  phosphate-buffered  saline  (PBS),  pH  7.2,  immediately  before 
loading of the ABA suppressor  factors. The absorption of the factor was performed at 4°C by 
allowing 5  X  10  s  cell equivalents  of suppressor  factor  in  1 ml  to  enter  the  gel  matrix;  the 
suppressor factor was allowed to remain in the column for at least 60 min at 4°C. The column 
was then washed with at  least five times its own void volume of PBS, pH  7.2.  Such effluents 
were  termed  filtrates.  Materials  that  remained  adsorbed  to  the  column  were  rapidly  eluted 
with five bed volumes of a  glycine-HC1 buffer, pH 2.8. The collected eluate was immediately 
neutralized to pH 7.0 with  1 N  NaOH as the material emerged from the column bed. Both the 
filtrate and the eluate were concentrated to the original volume by negative pressure dialysis at 
4°C and were thereafter frozen at -40°C. Such materials were thawed immediately before use. 
Cell Fractionation; Removal of B Cells.  B cells were removed by a  modification of the method 
described by Mage et al. (15).  4 ml of rabbit antimouse immunoglobulin (RAMIg) prepared as 
described  (16)  at  a  concentration  of 0.7-1.0  mg/ml  in  PBS  were  added  to  100  X  15  mm 
polystyrene petri dishes (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) for 
1 h at room temperature. Plates were washed extensively with PBS, pH 7.2, and then incubated 
for 20 rain with 4  ml PBS with 5% phosphate-buffered  saline containing 5% fetal calf serum 
(PBS-5)  before  addition  of splenic  cells.  After  removal  of PBS-5,  60  75  X  10  ~ spleen  cells 
depleted of erythrocytes by incubation with 0.83%  (Tris) NH4CI were added to each plate in a 
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incubation, nonadherent cells were  removed by gently swirling and washing the plates with 
PBS-5. These nonadherent populations contained approximately 5-8% surface immunoglobu- 
lin-bearing  cells as judged by immunofluorescence using fluorescinated-RAMIg. 
Purification of Ts on ABA-BSA and Idiotype-coated Plates.  Specific suppressor cells were separated 
according to  a  modification of the  method  of Taniguchi and  Miller  (17). ABA-BSA was 
prepared as described (18). ABA-BSA coated plates were prepared by overnight incubation of 
4 ml ABA-BSA at a concentration of 1 mg/ml on 100 ×  15 mm polystyrene Petri dishes at 4 ° 
C. The ABA-BSA solution was then removed, the plates washed as indicated above for RAMIg, 
and after removal of the PBS-5,  rinsed with PBS before addition of T  cells. A/J anti-ABA 
antibodies which contain 20-70% CRI were prepared as described (19). CRI-coated dishes were 
prepared according to a modification of the method of Abbas et al.  (20). Briefly, 4 ml of CRI 
(0.5-1.0 mg/ml in PBS) were incubated on 100 ×  15 mm polystyrene Petri dishes for 2-3 h at 
room temperature. After removal of immunoglobulin solutions, the plates were  washed with 
PBS, incubated 20-30 min with PBS-5, and washed extensively with PBS before the addition 
of T cells. 60-65 ×  106 plate-purified T  cells were added to antigen-coated plates or idiotype- 
coated plates in a  total volume of 5 ml PBS-5.  These cells were incubated for  1 h  at  20°C. 
ABA-BSA plates were gently rocked at the midpoint of incubation. Nonadherent cells were 
then removed from ABA-BSA plates with three cycles  of swirling and washing with warm 
(20°C) PBS-5. Nonadherent cells were removed from CRI-coated plates with two such cycles. 
Then 5 ml of chilled PBS-5  was added to all plates, which were then placed at  4°C for  a 
further 30 min. The adherent cells were suspended by vigorous pipetting. After two additional 
chilled PBS-5 washes with vigorous pipetting, the adherent cells were pooled, spun at 200 g for 
10 min, resuspended in PBS-5,  and counted. The cells were divided into groups, washed two 
times with chilled HBSS, and brought to appropriate volume before transfer. These separation 
procedures routinely yielded a T  cell population equal to 35-50% of the original spleen cells 
added to the RAMIg plates; cells adherent to ABA-BSA or CRI-coated dishes  comprised 5- 
15% of the applied T cell population or ~2-7% of the total spleen cell population. 
Statistical  Analysis.  Analysis of the  differences  of data  obtained was  performed  with  the 
Wang programmable computer.  The  means and standard error  of the  mean  (SEM)  were 
expressed, as well as the relevant P value obtained with the two-tailed Student's t test. 
Results 
Induction  of Ts  by  TsF.  Previous studies  have  revealed  that  subcellular antigen 
binding materials obtained from T  cells of animals treated 7 d  earlier with ABA-SC 
but  not  from  T  cells of normal animals, can  suppress  ABA-specific DTH  (7).  To 
characterize  further  the  mechanism of action of TsF, we  investigated whether  the 
inhibitory effect  of TsF was  due to  their ability to  induce Ts2  in the  recipients, a 
property shared by many suppressor factors in other systems (3, 4,  13). 
TsF were injected intravenously into groups of normal A/J mice for 5 successive d 
(2  X  107 cell equivalents/d) as described in Materials and Methods  (7).  On day  7, 
these  mice served as  donors of putative Ts2.  Single cell  suspensions were  prepared 
from the spleen, and before transfer to naive syngeneic recipients, two of the groups 
were  treated  in  vitro  with  either  normal  mouse  serum  (NMS)  or  anti-Thy  1.2 
antiserum and complement. The recipients of such spleen cells were immunized with 
ABA-SC subcutaneously and challenged 5 d  later. 
The results of a  representative experiment are depicted in Fig.  1. As can be seen, 
spleen cells obtained from normal untreated animals were unable to suppress ABA 
DTH  upon transfer. However, spleen cells obtained from animals which have been 
treated with TsF for 5 successive d produced a significant inhibition  of DTH reactivity 
upon transfer to  normal recipients. Furthermore, treatment with  anti-Thy 1.2  and 
complement, but  not  NMS  and  complement resulted  in  a  complete  loss  of their 
suppressive activities. Therefore, the phenomenon of suppression is T  cell dependent. SY,  DIETZ, GERMAIN, BENACERRAF,  AND GREENE  1187 
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Ftc.  I.  Induction  and  characterization  of suppressor  cells with  TsF.  Normal  A/J  mice  were 
injected with  2 x  107 cell equivalents/d of TsF i.v. for 5 successive d. On d  7, 5  X  10  7 viable 
spleen cells from these animals were transferred to naive recipients. Two of the groups were treated 
in vitro with either anti-Thy 1.2 antiserum or normal mouse serum (NMS) andcomplement before 
transfer. All recipients and appropriate controls were immunized  with 3 x  10' ABA-SC subcuta- 
neously within  2 h of cell transfer. 5 d later, they were challenged  in the footpad  with  30 #1 of 
diazonium  salt  of p-arsanilic  acid,  and  the  increase  in  footpad  swelling was  measured  24  h 
postchallenge. Bars represent the mean footpad swelling of at least four mice :l: SEM. 
In accord with  earlier observations  (9-12),  the  in  vivo treatment  with  TsF induces 
Zs2. 
Characterization of TsF Which Induces Ts2.  We  have  demonstrated  previously that 
TsF which inhibits ABA-specific DTH  does not bind to antibody, or to immunoglob- 
ulin (2n or CL determinants.  However, TsF activities can be removed upon passage 
through anti-idiotypic or appropriate anti-H-2 immunoadsorbent columns (7, 8). To 
delineate further whether  the suppressive principle associated with  the above men- 
tioned TsF  molecule is the same which  is responsible for the activation of Ts2,  we 
passed TsF from A/J  mice through  a  variety of immunoadsorbent  columns.  There- 
after, the filtrate and the acid eluate from such columns were tested for their ability 
to induce Ts2. 
The results of one such experiment are shown in Fig. 2. The data clearly demonstrate 
that the ability to induce Ts~ in normal mice was present only in the filtrate and not 
in  the  acid  eluate  fractions  obtained  when  TsF  was  passed  through  a  RAMIg- 
Sepharose  immunoadsorbent  column.  In  contrast,  Ts2-inducing  activity can  be  re- 
covered in the acid eluate fraction when TsF was passed on either an anti-idiotypic 
or an anti-I-J  k immunoadsorbent column. From these observations, we conclude that 
the molecules responsible for the suppressive activities studied previously, and for Ts2- 
inducing ability share similar structural features including a lack of Ig constant region 
determinants, and cannot be distinguished at this time. 
In  Contrast with  Tsl,  Ts~  Are  Resistant  to  Lysis  with  Anti-Idiotypic  Antibodies  and 
Complement.  Experiments from  many different experimental systems have provided 
evidence  that  Tsx  bear  idiotypic determinants  on  their  surface  (16,  21).  However, 
there  are  also  data  indicating that  Ts  with  similar suppressive  activity may  carry 
anti-idiotypic receptors  (22-24).  Recently, we have found that  in vitro treatment  of 
Ts  induced  by ABA-SC  in  A/J  mice  with  anti-CRI  and  complement  results  in  a 
complete loss of their suppressive activities. In contrast, when Ts were induced with 1188  ANTIGEN- AND RECEPTOR-DRIVEN REGULATORY MECHANISM 
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Fzo.  2.  Characterization of the principal components in the TsF complex which is responsible  for 
the  induction  of Ts2. 5  ×  108  cell  equivalents  of TsF  in  1 ml  were  passed  through  different 
immunoadsorbent  columns as described in Materials and  Methods.  Both the filtrate and  eluate 
from each column were concentrated back to the original volume, and injected into separate groups 
of normal A/J mice over 5 successive d. On day 7, 5 X  10  7 viable spleen cells from each individual 
groups were transferred to groups of naive recipients.  All recipients and appropriate controls were 
immunized with 3 X  10  7 ABA-SC subcutaneously within 2 h of cell transfer.  5 d later, they were 
challenged in the footpad with 30/d of diazonium salt ofp-arsanilic acid, and the increase in footpad 
swelling was measured 24 h postchallenge.  Bars represent the mean footpad swelling of at least four 
mice ± SEM. The number in parentheses  indicates the percentage of suppression  transferred.  It was 
calculated according to the following formula: 
=  (  positive contro_l-- experimental 
Percent tolerance  \positive control -  negative control,/ X 100. 
different  haptenated  cells  (i.e.,  trinitrobenzenesulfonic  acid-derivatized  cells  [TNP- 
cells]) or in animals which do not possess the necessary genetic information to express 
CRI  determinants  (i.e.,  BALB/c)  these  Ts  were  insensitive  to  the  same  treatment 
(Unpublished  results.).  In  an  attempt  to  compare  Ts  induced  by  antigen  to  those 
induced  with  Tsrderived  TsF,  we  examined  the  effect  of anti-idiotypic  antibodies 
and complement  treatment  on these two types of Ts. 
The results of a  typical experiment  are depicted in Fig. 3. TSl induced by ABA-SC 
are sensitive to treatment with anti-idiotypic antibodies and complement. In contrast, 
the  same  treatment  did  not  discernibly  affect  the  ability  of Ts2  induced  by  TsF  to 
transfer suppression.  Thus, Ts induced  by antigen  (ABA-SC) bear idiotypic determi- 
nants on their surface whereas Ts2 appear  to lack these determinants. 
Enrichment of Ts2 with Idiotype-coated Dishes.  The  ability of Ts  to  bind  directly  to 
either antigen  columns  (25)  or antigen-coated  plates  (17)  has  permitted  the positive 
selection of such  antigen-induced  Ts.  Similarly, Ts induced  by intravenous  injection SY,  DIETZ,  GERMAIN,  BENACERRAF, AND GREENE  1189 
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F[o. 3.  Characterization of Tsl and Ts2 with respect to their sensitivity to in vitro treatment with 
anti-CRI  antibodies and complement. Normal A/J  mice were injected with 5 ×  107 ABA-SC 
intravenously and were the donors ofTs~. Ts2 were induced by injection of TsF over 5 successive  d 
(2 ×  107 cell equivalents/day). On day 7, single cell suspensions  were prepared from their spleens 
and, before transfer to naive recipients, the cells were treated in vitro with either normal rabbit 
serum (NRS) or anti-CRI antibodies and complement. 5 ×  107 viable cells were then transferred to 
different groups of naive recipients. All recipients and appropriate controls were immunized with 3 
×  107 ABA-SC subcutaneously within 2 h of cell transfer. 5 d later, they were challenged in the 
footpad with 30 #l of diazonium salt ofp-arsanilie acid and the increase in footpad swelling was 
measured 24 h later. Bars represent the mean footpad swelling  of at least four mice + SEM. 
of ABA-SC can be positively enriched on ABA-BSA but not TNP-BSA-coated plates. 
Such procedures usually produce a  16-50-fold enrichment of Ts when compared with 
the whole spleen population (Dietz, M. H. Manuscript in preparation.). 
To  investigate the  specificity  of Ts2  induced  by  CRI  ÷  TsF  as  compared  with 
antigen-specific Tsl induced by antigen, we examined whether Ts2 bind to idiotype- 
coated plates. 
The results of such an experiment are presented in Fig. 4. Ts induced by intravenous 
injection of ABA-SC can be enriched on ABA-coated plates, since cells which adhere 
to ABA-BSAocoated plates transfer significant suppression to naive recipients. How- 
ever, ABA-SC-induced Ts do not adhere to idiotype-coated plates. In contrast with 
this binding characteristic of Ts induced by antigen, Ts2 induced by TsF adhere to 
idiotype-coated plates but not to antigen-coated plates. In addition, the Ts2 are not 
enriched on normal mouse Ig plates (Data not shown.). Thus, Ts induced by antigen 
bind to antigen, while Ts induced by CRI+ TsF bind to idiotype, indicating an anti- 
idiotypic specificity for these Ts2, consistent with their failure to be lysed by anti-CRI 
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FIG. 4.  Antigen induced Ts] binds to antigen plates while Ts2 induced by TsF binds to CRI plates. 
Normal A/J mice were injected with 5 x  107 ABA-SC intravenously  once or 2 X 107 cell equivalents 
of TsF per day for 5 successive  d. On day 7, they were the donors of Tst and Ts2, respectively.  Single 
cell suspensions  were prepared from their spleen and a portion of the spleen cells were separated on 
different plates as described in Materials and Methods. Cells adhering to ABA-BSA  or CRI plates 
were collected and transferred to  different groups of naive recipients in  various numbers. All 
recipients and appropriate controls were immunized with 3 x  107 ABA-SC subcutaneously within 
2 h of cell transfer. 5 d later, they were challenged in the footpad with 30 #1 of diazonium salt ofp- 
arsanilic acid and increase in footpad swelling was measured 24 h later. Bars represent the mean 
footpad swelling  of at least four mice + SEM. 
Discussion 
The data presented above serve both to extend previous observations on the activity 
of soluble TsF (3, 4, 7-13, 25-30) by demonstrating that ABA-TsF also act to induce 
Ts2 when administered to an immunologically naive recipient, and to provide new 
insight into the role of idiotypic interactions in cell to cell communication between T 
lymphocyte subsets, by directly demonstrating the ability of a  nonimmunoglobulin, 
T  cell-derived product to initiate an anti-idiotypic response. 
Antigen-specific Ts  regulate  immunity at  various  levels.  Previous  studies  have 
indicated that (a) the generation of immune cells (27) or (b) their functional expression 
(28, 29) can be limited by Ts in different systems. These have been termed afferent or 
efferent suppression, respectively. The studies herein do  not  directly address  which 
phase of the ABA-specific immune response is dampened by either Tsl or Ts2 cells. 
Nevertheless, many aspects of suppression in at  least three well investigated systems 
are striking in their similarities, with respect  to both  the  functional and structural 
characteristics of their  responsible T  cells  and  suppressor  factors.  Thus suppressor 
systems in the  mouse specific for the synthetic copolymers GAT  (4,  9,  10,  30),  GT 
(11),  and ABA  (7,  8)  are all characterized  by the presence of a  cyclophosphamide- 
sensitive antigen-specific cell which develops into the Tsl cell. This cell produced TsF 
which,  in  both  systems,  bears  cross-reactive  idiotypic determinants as  well  as  I-J- 
encoded specificities. In previous studies in the ABA system  (7,  8)  polyvalent rabbit SY,  DIETZ, GERMAIN, BENACERRAF, AND GREENE  1191 
anti-mouse F(ab')2 with specificity for #, 7, a, )~, ~ determinants was unable to remove 
any of the ABA-specific TsF activity. Similarly, anti-H-2 subregion antiserum (exclu- 
sive of anti-I-J antibodies) could not deplete TsF of its suppressive capacity. Similar 
work  in  the  GAT  system  has  revealed  that  only  anti-idiotypic  (anti-cross-reactive 
idiotype of anti-GAT antibodies)  or relevant  I-J antibodies could  interact with  the 
TsF molecule elaborated by GAT specific Tsl (30). Furthermore, the active superna- 
tants obtained from Tsl in the GAT and ABA as well as other suppressor systems (29) 
are characterized  by the ability of these materials to induce  the production  of Ts2. 
Thus,  there  are  many concordant  features  of suppression  in  distinct  systems,  one 
operative to limit the DTH reactivity to ABA, and the other to limit the production 
of antibodies to GAT. 
The major questions  that  were raised  during  these  studies  were  (a)  is  the  active 
material which suppresses ABA-specific immunity identical with that which induces 
Ts2 and (b) can suppressive activity of TsF result in part or entirely from its ability to 
stimulate the generation of Tsz? The data obtained in these studies strongly suggest 
that the two materials are identical and produced by similar, if not the same, cell. Tsl 
are idiotype-positive cells as deduced by their ability to be lysed by anti-idiotype and 
complement  and  furthermore  bind  selectively to  ABA-coated  plates.  Recently,  we 
have shown  in  preliminary experiments that  Tsl cells which  elaborate TsF used  to 
induce  Ts2,  also  bind  to ABA-coated  plates  and  are sensitive  to anti-idiotype  and 
complement lysis (Unpublished result.). Hence, the cellular source of both suppressive 
materials is the same. Immunochemical analysis of the TsF endowed with the capacity 
to stimulate Tsz studied herein was accomplished by passage through well character- 
ized immunoadsorbent columns. Such treatments clearly indicated that the material 
studied  here  has  the  same structural  features  as  the  TsF  previously characterized. 
These features are the presence of CRI  ÷ determinants and I-J-encoded specificities. 
Hence, by these criteria, the material which  stimulates Ts2 and that which  inhibits 
specific ABA reactivity are identical. 
We have as yet not entirely defined the respective roles of Tsl or Ts2. However, in 
experiments to be reported elsewhere, we have observed that TSl cells do not suppress 
ABA DTH late in the immune response whereas Ts2 cells do (Unpublished results.). 
Thus, Tsl may only function  by virtue of the generation of Ts2 cells.  More detailed 
analysis of the  functional  properties of these Tsl or Ts2 cells, however, is needed  to 
elucidate their respective roles in immune regulation. It should be noted that a similar 
idiotype-anti-idiotype-determined T  cell suppression occurs in  the regulation  of the 
immune response to the 4-hydroxy-3-nitrophenyl hapten in mice of the appropriate 
Igh-1 allotype (31).  Furthermore, both idiotype- and anti-idiotype-bearing TsF have 
been identified in A/J mice suppressed for the expression of the CRI antibodies (32). 
Another important  issue is the respective specificities of Tsl cells and Ts2 cells in 
this suppressor pathway, a matter which could be adequately investigated in the ABA 
system. The data presented establish  (a)  that  antigen-specific suppressor factor pro- 
duced  by  Tsl  cells  induces  idiotype-specific  Tsz  cells,  and  (b)  that  these  idiotype 
specific Ts2 cells can, upon adoptive transfer to a normal recipient, suppress its ability 
to develop ABA-specific DTH just as well as the passive transfer of an equal number 
of antigen-induced TSl cells.  However, before these data could be considered  firmly 
established,  in  view  of the  ability  of cell-bound  antibody  to  induce  similar  anti- 
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(33), certain critical controls had to be carried out to verify that the generation of Ts2 
cells was indeed stimulated  by the TsF in  the spleen supernate used.  The ability to 
stimulate TsF could not be absorbed by anti-Ig immunoadsorbent columns but could 
be  removed  by  and  eluted  from  anti-I-J  k  immunoadsorbent  columns;  these  are 
properties which are characteristic  of the immunochemical nature of the aforemen- 
tioned suppressor factor in contrast with antibody. We conclude, therefore, that the 
CRI  + TsF present,  in  amounts  too small to detect  so far by other than  functional 
tests, is highly effective in generating anti-idiotype Ts2. It remains to be determined 
whether in the GAT and GT systems that Ts2 induced by TsF are also anti-idiotype, 
a  matter which  is presently under  investigation.  Similarly, Eardley et al.  (34)  have 
suggested that the VH restriction observed between inducer and target suppressor T 
cell in the feedback suppression model may reflect idiotype-anti-idiotype interactions. 
Another prediction which could be made on the basis of the findings reported here 
is the existence of genetic restrictions controlled by VH genes, but not by MHC in the 
ability  of ABA  TsF  to  induce  suppression  in  recipient  mice.  Preliminary  results 
utilizing  allotype  congenics  and  H-2  congenic  strains  of mice  indicate  that  such 
restrictions indeed exist. 
The finding that Ts2-induced CRI-TsF bear anti-idiotype receptors is in agreement 
with the earlier observations of Owen et al. (22,  23)  who reported that Ts specific for 
the cross-reactive idiotype can be detected among T  cells from suppressed A/J mice 
hyperimmunized with  ABA-keyhole limpet  hemocyanin.  Similarly, Bona and  Paul 
(24) have recently identified naturally occurring T  suppressor cells with anti-idiotypic 
receptors specific for the  MOPC  460  myeloma protein.  In our own  laboratory, we 
have  also  determined,  as  stated  above,  that  the  suppressor  T  cell  induced  by 
intravenous immunization with CRI  + anti-ABA antibody conjugated to normal A/J 
spleen cells bear anti-idiotype receptors (Sy., M.-S. et al. Manuscript in preparation). 
The accumulated results from these and other laboratories demonstrating the involve- 
ment of idiotypic regulation at the T  cell level extend considerably the importance of 
the idiotype and anti-idiotype regulatory network first proposed byJerne (35), because 
the  T  lymphocytes appear  at  the  center  of critical  regulatory  interactions  in  the 
immune system. It is interesting also to speculate whether anti-idiotype Ts2 produce 
an I-J+ suppressor factor and whether such a factor is capable of inducing suppressor 
T  cells which would be anti-anti-idiotype or possibly antigen specific. Alternatively, 
the factor produced by Ts2 could be acting directly upon its target. 
The  results  in  the  ABA  system  presented  in  this  and  other  reports  from  our 
laboratory  lead  to  an  interesting  paradox.  Both  suppressor  cells  induced  by ABA 
suppressor factor documented in this study and those induced by CRI bearing anti- 
ABA  antibody  coupled  to  syngeneic  cells  are  anti-idiotype.  Yet,  they  are  able  to 
suppress upon adoptive transfer a  DTH response to ABA in syngeneic A/J mice, the 
effector cells of which appear not to bear idiotypic determinants, since they cannot be 
lysed by anti-idiotype and complement, whereas anti-idiotype-induced DTH effectors 
cells bear ABA CRI (36).  This apparent contradiction could be explained by (a)  the 
presence of idiotype in the precursors of the DTH effector cells,  (b)  the requirement 
for idiotype-specific helper T  cells which could be the target of the suppression, (c) the 
requirement  for the presence of another idiotype-positive T  cell subpopulation other 
than suppressor T  cells, TDH cells, or T  helper cells. This situation has been shown to 
occur in  the  2,4-dinitro-l-fluorobenzene  contact  sensitivity system  (37)  in  which  T SY,  DIETZ,  GERMAIN,  BENACERRAF,  AND  GREENE  1193 
auxiliary cells are required for suppression; and an additional reason,  (d)  the ability 
of small amounts of idiotype-positive anti-ABA antibody concomitantly produced to 
bind with the TDH cells after their interaction with antigen; such antibody could focus 
anti-idiotype Ts cells on the relevant TDH cell.  Experiments are now in  progress to 
examine the aforementioned possibilities. 
Lastly, if, as we are proposing, the stimulation of Ts2 idiotypic determinants of the 
TsF has any in vivo relevance, we should be able to detect in the same animal first 
the  idiotype-bearing Tsa,  followed  by the  appearance  of anti-idiotypic Ts2  in  the 
course of tolerization with ABA-SC. 
Summary 
Administration of azobenzenearsonate (ABA)-coupled syngeneic spleen cells  intra- 
venously to A/J mice leads to the generation of suppressor T  cells (Ts0 which exhibit 
specific binding to ABA-bovine serum albumin (BSA)-coated dishes. These Tsa share 
idiotypic determinants with the major cross-reactive idiotype (CRI) of the anti-ABA 
antibodies of A/J mice, and also produce a  soluble suppressor factor (TsF)  bearing 
CRI and I-J subregion-coded determinants. Injection of this TsF into naive A/J mice 
elicits a  second set  of specific suppressor cells  (Ts2) which are not lysed by anti-CRI 
antibody plus  C,  and  which  do not  bind  to ABA-BSA-coated dishes.  However,  in 
contrast with Tsl, these Ts2 do bind to plates bearing CRI  + anti-ABA immunoglob- 
ulin.  Thus,  Ts2  exhibit  anti-idiotypic specificity.  These  data  indicate  that  antigen 
elicits the production of a soluble T  cell product bearing both variable portion of the 
Ig heavy chain  (VH) and I-J subregion-coded determinants which serves to commu- 
nicate between T  cell subsets to establish an idiotype-anti-idiotype regulatory path- 
way. 
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